Giving statins before percutaneous coronary intervention (PCI) lowers the risk of 30-day events compared with post-PCI initiation or no or low-dose statins in patients with acute coronary syndromes ...

Patients with acute coronary syndromes (ACS) with later bleeding complications that were at least moderate in severity showed a 15-fold increased risk of dying within 30 days compared with those ...

PARIS, France—The treatment of patients with acute coronary syndrome with PCI via the radial artery results in a significant reduction in major bleeding and major cardiovascular events when compared ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Despite fewer bleeding events, 1-month ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Long-term ticagrelor monotherapy after ...

Antiplatelet therapy has become a key factor in improving the short- and long-term outcomes following percutaneous coronary intervention (PCI). The Clopidogrel in Unstable Angina to prevent Recurrent ...

heart ecg A systematic review and meta-analysis published in the American Journal of Cardiovascular Drugs compared the safety and efficacy of prasugrel and ticagrelor in patients with acute coronary ...

SAN FRANCISCO, CA—Use of bivalirudin alone was superior to heparin alone with respect to all-cause mortality in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary ...

MIAMI, Oct. 23, 2012 /PRNewswire/ -- Daiichi Sankyo, Inc. and Eli Lilly and Company (NYSE: LLY) today announced new results of two retrospective, observational, comparative effectiveness studies of ...

"This study suggests that the ARC-HBR and PRECISE-DAPT bleeding criteria can be used to risk stratify patients and guide the therapeutic selection to lower the bleeding risk. For instance, we found ...

Dual antiplatelet therapy with a thienopyridine in combination with aspirin for 1 to 6 months after stenting has been recommended by the manufacturers to reduce ischemic cardiovascular events and ...